期刊文献+

血清白细胞介素-18、氧化低密度脂蛋白与急性心肌梗死患者急诊PCI术后支架内再狭窄的关系 被引量:4

Relationship between plasma level of IL-18,ox-LDL and the development of emergency percutaneous coronary intervention
原文传递
导出
摘要 目的:探讨血清白细胞介素-18(IL-18)、氧化低密度脂蛋白(ox-LDL)与急诊经皮冠状动脉介入治疗(PCI)术后支架内再狭窄的关系。方法:75例急性心梗急诊介入术后8~12个月内接受冠状动脉造影复查,其中9例有再狭窄作为再狭窄组,66例无再狭窄作为对照组。2组术后均接受阿司匹林、氯吡格雷、他汀类等药物治疗。取2组患者PCI术前、术后冠状动脉造影复查时血清标本,采用酶联免疫吸附法(EL ISA)检测血清IL-18、ox-LDL水平。结果:①再狭窄组PCI术后IL-18、ox-LDL水平较术前均明显升高[(2.37±0.22):(0.85±0.19)mg/L、(6.99±0.98):(2.38±1.06)mg/L],均P<0.01;对照组PCI后IL-18、ox-LDL水平较术前明显下降[(0.48±0.11):(1.23±0.09)mg/L、(1.39±0.54):(4.45±0.87)mg/L],P<0.05。②再狭窄组和对照组PCI术前IL-18、ox-LDL水平差异无统计学意义,再狭窄组PCI术后IL-18、ox-LDL水平显著高于对照组(均P<0.01)。④再狭窄组和对照组术前、术后IL-18和ox-LDL水平均呈正相关。结论:PCI术后再狭窄患者血浆IL-18及ox-LDL水平明显升高,二者可作为PCI术后再狭窄的预测指标。 Objective: To investigate the relationship between serum level of interleukin-18,oxidized low density lipoprotein(ox-LDL) and the development of in stent restenosis after emergency percutaneous coronary intervention.Method: A total of seven-ty-five patients with successfully coronary stent implantation followed by coronary angiography within 8-12 months after emergency PCI were enrolled.patients with restenosis(n = 9) were assigned in restenosis group,and 66 patients in control group.Blood serum levels of IL-18 and ox-LDL were analysed in all cases before PCI and after PCI within 8-12 months.Blood serum IL-18,ox-LDL were mea-sured by ELISA.Result: Blood serum levels of IL-18 and ox-LDL were significantly higher than those before PCI in restenosis group(P0.01).The biomarkers were significantly lower than those before PCI in control group(P0.01).There was no significantly difference of IL-18 and ox-LDL levels between restenosis group and control group before PCI,but they were significantly higher in restenosis group than incont rol group after PCI(P0.01).There was a positive correlation between serum levels of IL-18 and ox-LDL in restenosis group as well as in control group before and after PCI.Conclusion: Both IL-18 and ox-LDL may be regarded as prognostic indicators in patients developing restenosis af ter coronary stenting.
出处 《现代生物医学进展》 CAS 2010年第24期4704-4706,共3页 Progress in Modern Biomedicine
关键词 急诊冠状动脉介入治疗 白细胞介素-18 氧化低密度脂蛋白 再狭窄 emergency percutaneous coronary intervention interleukin-18 oxidized low-density lipoprotein coronary artery restenosis
  • 相关文献

参考文献10

  • 1刘晓红,洪苍浩,汤国法,李裕舒.氧化低密度脂蛋白、高敏C反应蛋白与冠状动脉支架置入术后再狭窄的关系[J].临床心血管病杂志,2010,26(5):326-328. 被引量:16
  • 2Thompson SR, Sanders J, Stephens JW, et al. A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease[J]. Metabolism, 2007, 56(5): 662-669.
  • 3Tsimikas S, Witztum J L. Measuring lipoprotein to evaluate coronary risk 1932 circulating oxidized low-density [J]. Circulation, 2001,103:1930-1932.
  • 4Zohln H; Fer D, Hausl Eiter J, Kastrati A, et al. A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib [J]. JACC, 2005,46:1999- 2003.
  • 5Espinola-Klein C, Ruppreeht HJ, Bickel C, et al. Inflammation, atherosclerotic burden and cardiovascular prognosis[J]. Atheroselerosis, 2007, 195(2): e126-134.
  • 6孙文长.白细胞介素18研究进展[J].国外医学(临床生物化学与检验学分册),2000,21(2):57-59. 被引量:31
  • 7Zirlik A, Abdullah SM, Gerdes N,et al. Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study [J]. Arterioscler Thromb Vase Biol, 2007, 27 (9): 2043-2049.
  • 8Chen MC, Chert CJ, Yang CH,et al. Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina[J]. Heart Vessels, 2007, 22(6): 371-375.
  • 9Blankenberg S, Godefroy T, Poirier O, et al. Haplotypes of the easpase-1 gene, plasma caspase-1 levels, and eardiovaseular risk [J]. Cire Res, 2006, 99(1): 102-108.
  • 10Iwata A, Miura S, Shirai K, et al. Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction[J]. Intem Med, 2006,45:885 - 890.

二级参考文献25

  • 1张家明,王朝晖,李大强,冯义柏.急性冠状动脉综合征患者氧化低密度脂蛋白与细胞因子的变化及其相关性[J].临床心血管病杂志,2005,21(4):212-214. 被引量:6
  • 2ZOHLNHOFER D, HAUSLEITER J, KASTRATI A, et al. A randomized, double-blind, placebo-controlled trial on restenosis preverition by the receptor tyrosine kinase inhibitor imatinib [J]. JACC, 2005, 46:1999-2003.
  • 3ROSS R. Atherosclerosis: an inflammatory disease [J]. Nature, 1999,340 : 115- 126.
  • 4TSIMIKAS S, WITZTUM J L. Measuring circulating oxidized low density lipoprotein to evaluate coronary risk[J].Circulation, 2001,103 : 1930-1932.
  • 5AUER J, LEITNER A, BERENT R, et al. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation [J]. Atherosclerosis, 2009. [Epub ahead of print].
  • 6FRALEY A E, TSIMIKAS S. Clinical applications of circulating oxidized low-density lipoprotein biomark ers in cardiovascular disease[J]. Curr Opin Lipidol, 2006,17:502-509.
  • 7BRAUN S, NDREPEPA G, VON BECKERATH N, et al. Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting [J]. Am Heart J, 2005,150:550-556.
  • 8NARUKO T, UEDA M, EHARA S, et al. Persis tent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis[J]. Arterioscler Thromb Vasc Biol,2006, 26:877-883.
  • 9IWATA A, MIURA S, SHIRAI K, et al. Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction[J]. Intern Med,2006,45:885-890.
  • 10ZEBRACK J S, ANDERSON J L, MAYCOCK C A, et al. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocar dial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction[J]. Am J Cardiol, 2002,89 : 145 - 149.

共引文献45

同被引文献43

  • 1肖长华,杨希立,许兆延,周昭仑.氧化低密度脂蛋白和血管内超声预测介入术后支架内再狭窄[J].岭南心血管病杂志,2008,14(6):411-414. 被引量:1
  • 2George J, Harats D, Bakshi E, et al. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty[ J]. Immunol Lett, 1999,68 (2 - 3 ) : 263 - 266.
  • 3Segev A, Strauss BH, Witztum JL, et al. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina[ J]. Am Heart J,2005,150(5):1 007-1 014.
  • 4Naruko T, Ueda M, Ehara S, et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis [ J ]. Arterioscler Thromb Vasc Biol,2006,26 (4) : 877 - 883.
  • 5Stmup DF,Bertin JA,Mton SC,et al. Meta-analysis of obserbatnal studies in epidemiology:a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology(MOOSE) group[ J ]. JAMA,2000,283 ( 15 ) :2 008 - 2 012.
  • 6Higgins J,Green S. Cochrane Handbook for systematic reviews of interventions[M]. United state: The Cochrane Callaboration, 2008:501.
  • 7Weh FG, Rogers C. Inflammation and restenosis in the stent era [ J ]. Arterioscler Thromb Vasc Biol, 2002, 22 ( 11 ) : 1 769- 1 776.
  • 8Jir6 S,Saku K,Kusaba H,et al. Deposition af oxidized low-&nsity lipoprotein and collagenosis occur coincidentally in human coronary stenosis :an immunohistochemical study of atherectomy [J]. Coron Artery Dis,1998,9(9) :551 -557.
  • 9Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques:implications for plaque stabilization [ J ]. Circulation,2001,103 (7) :926 - 933.
  • 10Nishi K, Itabe H, Uno M, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability [ J ]. Arterioscler Thromb Vasc Bio1,2002 ,22 (10) : 1 649 - 1 654.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部